Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

31861 - 31870 of 57753 results found

Potent antibodies against immune invasive SARS-CoV-2 Omicron subvariants

Date
Thursday, July 27, 2023 - 4:00 AM
Description
The development of neutralizing antibodies (nAbs) is an important strategy to tackle the Omicron variant. Omicron N-terminal domain (NTD) mutations including A67V, G142D, and N212I alter the antigenic structure, and mutations in the spike receptor